Sandeep Wagle of powermywealth.com told CNBC-TV18, "I would recommend a hold Aurobindo Pharma with a stoploss of Rs 610. I would talk of the next 12-15 months, I would talk of Rs 850-870 kind of a target and then we will revise it if required."
He further added, "I have much higher targets over a two to three year time horizon, so a hold as of now. I would want to give a disclosure that I personally hold it in my portfolio as well as my family portfolio."
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!